Suppression of tumor growth by intra-muscular transfer of naked DNA encoding adrenomedullin antagonist.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 39, doi. 10.1038/sj.cgt.7700979
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2007 AND VI 14 AND IP 1
Results: 13
1
2
Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 45, doi. 10.1038/sj.cgt.7700978
- By:
- Publication type:
- Article
3
Sensitivity of 5-fluorouracil-resistant cancer cells to adenovirus suicide gene therapy.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 57, doi. 10.1038/sj.cgt.7700980
- By:
- Publication type:
- Article
4
Inhibition of hepatocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 66, doi. 10.1038/sj.cgt.7700985
- By:
- Publication type:
- Article
5
Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 1, doi. 10.1038/sj.cgt.7700986
- By:
- Publication type:
- Article
6
Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 19, doi. 10.1038/sj.cgt.7700987
- By:
- Publication type:
- Article
7
Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 12, doi. 10.1038/sj.cgt.7700989
- By:
- Publication type:
- Article
8
Gene therapy of liver tumors with human liver-specific nanoparticles.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 74, doi. 10.1038/sj.cgt.7700990
- By:
- Publication type:
- Article
9
Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 105, doi. 10.1038/sj.cgt.7700991
- By:
- Publication type:
- Article
10
Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 82, doi. 10.1038/sj.cgt.7700992
- By:
- Publication type:
- Article
11
Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 91, doi. 10.1038/sj.cgt.7700993
- By:
- Publication type:
- Article
12
Enriching suicide gene bearing tumor cells for an increased bystander effect.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 30, doi. 10.1038/sj.cgt.7700995
- By:
- Publication type:
- Article
13
Persistent mismatch repair deficiency following targeted correction of hMLH1.
- Published in:
- Cancer Gene Therapy, 2007, v. 14, n. 1, p. 98, doi. 10.1038/sj.cgt.7700997
- By:
- Publication type:
- Article